Breasts during menopause: pain, lumps, and what's normal

During the transition to menopause, estrogen and progesterone levels fluctuate and then decline. This leads to gradual involution of glandular breast tissue, a relative increase in adipose and connective tissue, and changes in receptor sensitivity. These changes give rise to typical complaints: engorgement, soreness, tingling, a burning sensation, and a subjective "nodularity." These symptoms are often functional and not associated with cancer, but require careful triage at the initial consultation. [1]

Classically, a distinction is made between cyclical pain, non-cyclical pain, and so-called extraglandular pain, when the source is located in the chest wall or spine, and the discomfort is projected to the chest. During perimenopause, pain is often "mixed" in nature due to hormonal fluctuations, changes in tissue density, and concomitant musculoskeletal causes. Correct classification facilitates diagnosis and treatment selection. [2]

It's important to remember: breast pain alone rarely indicates cancer. Large reviews and clinical pathways indicate an extremely low incidence of cancer in isolated pain without other symptoms, so most patients do not require urgent referral to an oncologist, but rather a high-quality initial examination, support, and targeted treatment. Exceptions include clear "red flags." [3]

A separate issue is the effect of hormone replacement therapy on the breast. During the first few months, it can increase sensitivity and tissue density on a mammogram. These effects are predictable, manageable by changing the regimen, and are not equivalent to tumor development, although they require careful monitoring and adherence to screening. [4]

Table 1. Main types of chest pain and their key signs

Type	How does it feel?	What is most often the basis?	What helps at the start
Cyclic	Bilateral, diffuse, intensifies during menstruation	Hormonal fluctuations during perimenopause	Support, proper bra, topical nonsteroidal anti-inflammatory drugs
Non-cyclical	Local, constant or with long episodes	Cysts, fibrocystic changes, large breast sizes	Ultrasound control as indicated, local remedies, rare cases - prescription drugs
Extraglandular	Pain in the chest wall, worsens with movement	Costochondritis, muscular and neurogenic causes	Load correction, manual and physiotherapeutic approaches, local remedies

Based on modern reviews and guidelines.[5]

How Breast Tissue Changes During Menopause

A decrease in estrogen and progesterone leads to a decrease in the proportion of glandular epithelium, an increase in the proportion of adipose tissue, and stromal remodeling, which alters the mechanical and sensory properties of the breast. This is commonly felt as "flabbiness" or, conversely, tension and tingling during exercise. These normal age-related changes are not dangerous in themselves, but are compounded by individual characteristics and associated factors. [6]

During perimenopause, hormonal fluctuations create "windows of vulnerability" when engorgement and soreness intensify in waves. This is due to changes in the stroma and ducts, as well as fluctuations in prolactin and pain mediators. Therefore, symptoms often fluctuate for weeks and months, even without noticeable external triggers. [7]

After menopause, tissue density generally decreases, which typically simplifies mammography interpretation. However, in some women, systemic hormone therapy can cause a reverse effect—a moderate increase in mammographic density, which reduces screening sensitivity and increases the likelihood of additional referrals for follow-up examinations. This is not a reason to abandon therapy, but it is important to consider when planning screening. [8]

Finally, age-related and hormonal changes affect pain sensitivity overall, including through neuromuscular mechanisms and microinflammation. Therefore, properly addressing lifestyle and musculoskeletal factors is often as effective as medication. [9]

Table 2. What is normal and what requires attention

Situation	More like a normal variant	Needs evaluation
Diffuse bilateral pain	Yes, especially during perimenopause.	If it is persistently localized and unilateral
Soft "balls" disappear during the cycle	Often	If the seal is hard, fixed, and does not disappear
Engorgement at the start of hormonal therapy	Often and temporarily	If it persists for more than a few months or is accompanied by nipple discharge
Tingling and burning without skin changes	It may be neuromuscular.	If there is "orange peel" appearance, nipple retraction, bloody discharge

The criteria are compiled from guidelines for primary care and specialty clinics. [10]

Red Flags: When Urgent Action Is Needed

Immediate consultation is required for a hard, uneven, poorly movable mass, progressive deformity, nipple retraction, asymmetry, bloody discharge from one duct, ulceration, or "orange peel" appearance. These signs increase the likelihood of significant pathology and require fast-track treatment. [11]

Isolated pain without the above-mentioned symptoms is extremely rarely associated with cancer. Large data shows a very low incidence of malignancy in the "pain only" group, so the primary tools remain a thorough examination, reassurance, observation, and targeted symptomatic therapy. [12]

If the pain is localized and unilateral, targeted ultrasound examination is warranted in women over thirty. If a mass is detected, the approach is standard: comparing clinical and imaging findings, followed by targeted biopsy if suspicious signs are present. [13]

In inflammatory symptoms with redness, tenderness, and increased skin temperature, mastitis and abscesses should be ruled out, especially in the presence of diabetes mellitus or immunosuppression. Antibacterial therapy and, if a cavity develops, drainage may be required. [14]

Table 3. Signs of immediate treatment

Sign	Why is it dangerous?	Act One
A hard nodule fixed to the skin or chest wall	Risk of malignancy	Urgent imaging and biopsy
Bloody unilateral discharge	Sign of duct pathology	Diagnostic imaging and cytological evaluation of secretions
Nipple retraction, orange peel appearance, ulcers	Skin-lipodystrophic changes in tumor	Accelerated routing
Rapidly increasing redness and pain	An infectious process is likely	Antibacterial tactics, exclusion of abscess

Sources: Cancer suspicion guidelines and clinical pathways.[15]

Diagnostics: from examination to "triple assessment"

The first step is a detailed history and physical examination: the nature of the pain, its duration, its relationship with exercise, caffeine, medications, the influence of a bra, the presence of trauma, weight changes, and family history. Palpation is performed in all four quadrants and the area of Spence's tail, and the skin and nipple-areolar complex are assessed. [16]

The "triple assessment" principle is then applied: clinical examination, imaging, and morphological verification if necessary. For women aged forty and older with symptoms beyond functional ones, diagnostic mammography, supplemented by ultrasound, is indicated. For women under thirty, targeted ultrasound examination begins, and mammography is prescribed as indicated. [17]

Imaging results are formalized using an international categorization scale with predictable recommendations for management. Understanding this scale helps explain to patients why additional testing or biopsy is sometimes required even for moderately suspicious findings. [18]

If all three components are consistent, the accuracy of the approach is close to the maximum for outpatient practice, avoiding unnecessary biopsies and diagnostic delays. Inconsistency in results is a reason for re-evaluation and in-depth imaging. [19]

Table 4. When and what study to prescribe

Clinical situation	Up to 30 years old	30-39 years old	40 and older
Isolated, diffuse pain, without any "flags"	Inspection, support, local resources	Inspection, support, local resources	Examination, support; if screening is overdue - mammography
Local pain or palpable mass	Targeted ultrasound examination	Targeted ultrasound examination	Diagnostic mammography plus ultrasound
Suspicious signs	Visualization and, if necessary, biopsy	Visualization and, if necessary, biopsy	Visualization and, if necessary, biopsy

The selection is based on primary care algorithms and triple bottom line principles. [20]

Breast cancer screening during menopause: what's new

Following updated recommendations from a large independent expert panel, regular mammography is recommended every two years, starting at age forty and continuing until age seventy-four, for women with average risk. For older age groups, there is insufficient evidence, and decisions are made on a case-by-case basis. The need for research on additional methods for women with dense breasts is specifically emphasized. [21]

These recommendations are consistent with the trend toward earlier screening due to the increasing incidence of the disease in the forty-year age group. However, the positions of different organizations on screening intervals may differ, so the final decision should be made in consultation with a physician, taking into account personal risk factors and the availability of tomosynthesis. [22]

If systemic hormonal therapy is being administered, it is advisable to maintain regular screening and retain previous examinations for comparison, as mammographic density and the number of "returns" for additional examinations may increase. This affects interpretation tactics but does not negate the benefits of screening. [23]

Table 5. Screening in practice

Parameter	What is accepted for average risk?	Comments
Age of onset	40	Individual solutions are possible depending on the risks
Interval	2 years	Reducing the interval is discussed individually.
Additional methods	According to the readings	If your breasts are dense, the issue is decided individually.
Conclusion	After 74 it is decided individually	Biological age and concomitant diseases are taken into account

Results for key positions of large organizations. [24]

The effect of hormonal therapy on the mammary glands

Hormone replacement therapy remains the most effective treatment for hot flashes and urogenital symptoms, although breast engorgement and tenderness may occur in the first few months. These symptoms usually resolve with adaptation. If severe discomfort occurs, the dose, route of administration, or type of progestogen is adjusted, and local estrogens may be added for urogenital symptoms. [25]

Systemic regimens can increase mammographic density and increase the frequency of return visits for additional examinations. This requires disciplined screening and storage of past images for proper comparison. [26]

Long-term breast risks depend on the combination of estradiol and progestogen, duration, and age of onset. Current approaches emphasize weighing the benefits and risks based on individual factors and the patient's priorities. With appropriate selection, benefits can be maximized and risks controlled. [27]

If hormones are contraindicated or ineffective against hot flashes, non-hormonal agents that act on central thermoregulatory mechanisms are available. These do not address structural breast changes, but they do reduce vasomotor symptoms and improve sleep, which indirectly reduces pain perception. [28]

Table 6. How to reduce pain during hormonal therapy

Approach	Practical step	For what
Reducing the dose of estradiol	Select the minimum effective dose	Reduce engorgement
Change of route of administration	Switch to transdermal forms	Stabilize levels and side effects
Progestogen optimization	Change the molecule or use an intrauterine system	Reduce breast sensitivity
Screening control	Maintain regularity and store images	Correct interpretation of density

Recommendations from clinical leaflets and guidelines for the management of menopause. [29]

What helps with pain: a ladder of interventions

The first step is information, proper supportive garment therapy, reduction of mechanical stress, addressing musculoskeletal pain factors, and short-term use of topical nonsteroidal agents. For some patients, this step alone is sufficient. [30]

Topical nonsteroidal diclofenac-based medications have a good evidence base for mastalgia and are preferable to systemic forms due to their improved safety profile and comparable efficacy. Initially, they are used in courses. [31]

For severe, persistent pain that impacts quality of life, short courses of prescription medications under specialist supervision are considered. Studies have shown the effectiveness of selective estrogen receptor modulators, but the decision is always individualized, taking into account the benefits and risks. [32]

Supplements such as evening primrose oil and modification of caffeine intake lack reliable evidence of significant effectiveness. They should be considered only as supportive measures, if desired, and not as a substitute for effective strategies. [33]

Table 7. Steps of care for chest pain

Step	What to do	When to move up
Basic	Explanation, bra selection, load correction, local non-steroidal agents	If after a few weeks it is not enough
Extended	Targeted physiotherapy, sleep and stress management, and treatment of associated causes	If pain persistently affects quality of life
Prescription options	Short courses prescribed by a specialist	For severe, persistent pain
Revision of tactics	Re-evaluation and visualization	When red flags appear

The basis is primary care and specialized reviews. [34]

Differential diagnosis: Not all pain comes from the chest

Costochondritis and myofascial syndromes of the chest wall often mimic "chest pain." Palpation of the costal articulations, increased pain with torso rotation and raising the arms, suggest a non-thoracic cause. Treatment includes load adjustments and topical agents. [35]

Cysts and fibrocystic lesions cause more localized, sometimes throbbing, pain. When in doubt, targeted ultrasound can be helpful. The presence of a tense cyst with significant discomfort is a reason for targeted evacuation of the contents and observation. [36]

Neurogenic causes, including cervical radiculopathy and intercostal neuralgia, produce burning, shooting pain with radiating effects. Neuromuscular rehabilitation and sleep monitoring are appropriate here, rather than aggressive "oncological" diagnostics in the absence of any red flags. [37]

Medication triggers also play a role. Some antidepressants, hormonal contraceptives, and hormone replacement therapy regimens can increase breast sensitivity, which is taken into account when adjusting the regimen. [38]

Table 8. How pain “not from the chest” differs from true mastalgia

Sign	Source in breast tissue	Non-glandular cause
Connection with cycles and hormonal fluctuations	Often there is	Usually no
Provocation by body movement	Not typical	Often expressed
A clear point of pain along the ribs	Not typical	Often there is
The effect of local non-steroidal drugs	Eat	This also happens often, but against the background of work with a load

Summary features from primary care reviews. [39]

Understanding Visualization Insights: What the Categories Mean

Mammography, ultrasound, and magnetic resonance imaging (MRI) results are standardized. Each category corresponds to the likelihood of significant pathology and the next step, from "continue routine screening" to "perform biopsy." Knowing these rules reduces anxiety and helps understand the logic behind the routing. [40]

The "incomplete" category indicates that additional projections or comparison with previous studies are needed, rather than simply stating that a tumor has been found. The "benign" and "probably benign" categories often lead to short-term observation. Suspicious categories are accompanied by targeted morphological verification. [41]

Table 9. How to interpret standard categories of conclusions

Category	Meaning	Typical next step
Incomplete	Additional images or comparison needed	Further examination and comparison with previous images
Negative or benign	There is no significant pathology	Routine screening
Probably benign	Low risk	Short interval control
Suspicious	Increased risk	Targeted biopsy

Brief summary of open materials from leading clinics. [42]

Frequently asked questions

Does breast pain alone indicate cancer?
No. With isolated pain without a lump or skin changes, the risk is extremely low. Examination, support, correction of factors, and observation are necessary. If any warning signs appear, the approach changes to an accelerated approach. [43]

What should you do with screening if you've started replacement therapy?
Maintain regular screening, keep previous studies for comparison, and inform your doctor about the therapy, as density may increase and additional scans may be needed. [44]

What treatments actually help with pain?
Topical nonsteroidal diclofenac-based medications offer the best benefit-to-safety ratio, along with bra changes and weight-bearing adjustments. For persistent, significant pain, consider short courses of prescription medications under specialist supervision. [45]

Do lifestyle changes need to be made?
Yes. Regular aerobic activity, strength training, and normalizing sleep and body weight can reduce musculoskeletal triggers for pain and improve overall tolerance of menopausal symptoms. [46]

Table 10. Home remedies that actually work

Measure	How to perform	What to expect
Support bra	Correct size, good fixation, no damaging bones	Reduction of microtrauma and discomfort
Load dosing	Increase activity gradually, avoid sudden jerks	Fewer musculoskeletal triggers
Local nonsteroidal agents	Courses according to instructions	Moderate pain relief
Sleep hygiene and stress management	Regular routine, dealing with anxiety	Reduced pain perception

Based on clinical pathways and primary care reviews.[47]